Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol.

Hvidovre Hospital, Kettegård Alle 30,2650 Hvidovre, Danmark

Special Issues: Magnesium in pregnancy

  Figure/Table
  Supplementary
  Article Metrics

References

1. Himpens E, Van den Broeck C, Oostra A et al. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. May 2008;50(5):334-40.

2. Wolf HT, Hegaard HK, Greisen G et al. Treatment with magnesium sulphate in pre-term birth: a systematic review and meta-analysis of observational studies. J Obstet Gynaecol J Inst Obstet Gynaecol. February 2012;32(2):135-40.

3. Doyle LW, Crowther CA, Middleton P et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1):CD004661.

4. Huusom LD, Secher NJ, Pryds O et al. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. BJOG Int J Obstet Gynaecol. January 2011;118(1):1-5.

5. Schonhaut L, Armijo I, Schönstedt M et al. Validity of the ages and stages questionnaires in term and preterm infants. Pediatrics. May 2013;131(5):e1468-1474.

Copyright Info: © 2015, Hanne Trap Wolf, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Article outline

Show full outline
Copyright © AIMS Press All Rights Reserved